Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Diabetes care revolution: training doctors to better control blood sugar

NCT ID NCT07124923

Disease control Sponsor: Institut Investigacio Sanitaria Pere Virgili Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether a structured training program for primary care doctors and nurses can help adults with type 2 diabetes achieve better blood sugar control. Over 7,700 patients in Catalonia will be followed for two years. The program includes hands-on training on diabetes management, heart risk reduction, and foot care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
structured training and feedback program for healthcare professionals
What this could lead to
If successful, this could show that training primary care teams improves diabetes control and reduces complications in a large population.
What could go wrong
This is a pragmatic trial focused on healthcare delivery, not a new drug. Results may vary by setting and may not apply outside this region.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 7,792 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Enrollment will begin in July 2025, aligned with the initiation of training sessions for healthcare professionals (physicians and nurses). Eligible participants must: * Be adults (≥18 years old) * Have an active diagnosis of T2DM documented in the eCAP primary care electronic health record system * Have a duration of T2DM of at least 12 months as of January 2025 Exclusion Criteria: * Diagnosis of type 1 diabetes mellitus (T1DM) * T2DM managed by a specialist at the time of inclusion * Current treatment with systemic corticosteroids * Active neoplasia (malignancy) * Gestational diabetes * Pregnancy or breastfeeding * Diagnosis of MACA (advanced chronic disease with life expectancy \<1 year) * Complex chronic patients (CCP) * Diagnosis of dementia * Institutionalized patients or those residing in social healthcare facilities * Age over 90 years * Age under 18 years * Severe psychiatric illness (e.g., psychosis, bipolar disorder, major depression) * History of kidney transplant * Undergoing dialysis * History of alcohol or drug abuse

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus type 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes mellitus type 2

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    12 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • ABS FLIX

    RECRUITING

    Flix, Tarragona, 43750, Spain

  • Abs Ametlla-Perelló

    RECRUITING

    El Perelló, Tarragona, 43860, Spain

  • Abs Ampolla-Aldea

    RECRUITING

    L'Ampolla, Tarragona, 43895, Spain

  • Abs Amposta

    RECRUITING

    Amposta, Tarragona, 43870, Spain

  • Abs Deltebre

    RECRUITING

    Deltebre, Tarragona, 43580, Spain

  • Abs Gandesa

    RECRUITING

    Gandesa, Tarragona, 43780, Spain

  • Abs La Ràpita-Alcanar

    RECRUITING

    Sant Carles de la Ràpita, Tarragona, 43540, Spain

  • Abs Mora La Nova

    RECRUITING

    Móra la Nova, Tarragona, 43770, Spain

  • Abs Tortosa Est

    RECRUITING

    Tortosa, Tarragona, 43500, Spain

  • Abs Tortosa Oest

    RECRUITING

    Tortosa, Tarragona, 43500, Spain

  • Abs Ulldecona

    RECRUITING

    Ulldecona, Tarragona, 43550, Spain

  • Hospital de Tortosa Verge de la Cinta

    RECRUITING

    Tortosa, Tarragona, 43500, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.